Belite Bio, Inc (BLTE) Tops Q4 EPS by 5c

Belite Bio, Inc (NASDAQ: BLTE) reported Q4 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.

You May Also Be Interested In

• Belite Bio, Inc, ADR (BLTE) PT Raised to $214 at H.C. Wainwright
• Innovaro (INV) Misses Q2 EPS by 9c
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c